Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

April 14, 2027

Study Completion Date

April 14, 2028

Conditions
Acute-On-Chronic Liver Failure
Interventions
DRUG

Low-dose experimental group

2.0\*10\^6/kg

DRUG

High-dose experimental group

4.0\*10\^6/kg

DRUG

Low-dose placebo control group

Equivalent volume of solvent calculated at 2.0×10\^6/kg

DRUG

High-dose placebo control group

Equivalent volume of solvent calculated at 4.0×10\^6/kg

All Listed Sponsors
lead

National Engineering Center of Cell Products

OTHER

NCT06884904 - Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF | Biotech Hunter | Biotech Hunter